Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 91

    1.

    Worsening of left ventricular end-systolic volume and mitral regurgitation without increase in left ventricular dyssynchrony on acute interruption of cardiac resynchronization therapy.

    Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D.

    Echocardiography. 2009 Aug;26(7):759-65. Epub .PMID: 19558521 [PubMed - in process]Related articles

    2.

    Hypertension, heart failure, and beta-adrenergic blocking drugs.

    Fowler MB.

    J Am Coll Cardiol. 2008 Sep 23;52(13):1073-5. No abstract available. PMID: 18848140 [PubMed - indexed for MEDLINE]Related articles

    3.

    Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.

    Witteles RM, Fowler MB.

    J Am Coll Cardiol. 2008 Jan 15;51(2):93-102. Review.PMID: 18191731 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.

    Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB.

    J Am Coll Cardiol. 2007 Nov 6;50(19):1835-40. Epub 2007 Oct 23.PMID: 17980248 [PubMed - indexed for MEDLINE]Related articles

    5.

    Why do we need to prevent right ventricular pacing?

    Tsiperfal A, Scheibly K, Fowler MB, Chao C.

    Prog Cardiovasc Nurs. 2007 Spring;22(2):108-9. No abstract available. PMID: 17541323 [PubMed - indexed for MEDLINE]Related articles

    6.

    Beta-blocker dosing in community-based treatment of heart failure.

    Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B, Massie BM, Abraham WT, Franciosa JA; COHERE Participant Physicians.

    Am Heart J. 2007 Jun;153(6):1029-36.PMID: 17540206 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.

    Massie BM, Nelson JJ, Lukas MA, Greenberg B, Fowler MB, Gilbert EM, Abraham WT, Lottes SR, Franciosa JA; COHERE Participant Physicians.

    Am J Cardiol. 2007 May 1;99(9):1263-8. Epub 2007 Mar 13.PMID: 17478155 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cardiomyopathy of insulin resistance.

    Witteles RM, Fowler MB.

    Heart Fail Clin. 2006 Jan;2(1):13-23. Review. No abstract available. PMID: 17386873 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.

    Abraham WT, Massie BM, Lukas MA, Lottes SR, Nelson JJ, Fowler MB, Greenberg B, Gilbert EM, Franciosa JA; COHERE Participant Physicians.

    Congest Heart Fail. 2007 Jan-Feb;13(1):16-21.PMID: 17268206 [PubMed - indexed for MEDLINE]Related articles

    10.

    Emerging therapies for the management of decompensated heart failure: from bench to bedside.

    deGoma EM, Vagelos RH, Fowler MB, Ashley EA.

    J Am Coll Cardiol. 2006 Dec 19;48(12):2397-409. Epub 2006 Nov 28. Review.PMID: 17174176 [PubMed - indexed for MEDLINE]Related articles

    11.

    Heart failure in community practice: relationship to age and sex in a beta-blocker registry.

    Franciosa JA, Nelson JJ, Lukas MA, Lottes SR, Massie BM, Fowler MB, Greenberg B, Gilbert EM, Abraham WT; COHERE Participant Physicians.

    Congest Heart Fail. 2006 Nov-Dec;12(6):317-23.PMID: 17170585 [PubMed - indexed for MEDLINE]Related articles

    12.

    Predictors of clinical outcomes in patients given carvedilol for heart failure.

    Greenberg B, Lottes SR, Nelson JJ, Lukas MA, Fowler MB, Massie BM, Abraham WT, Gilbert EM, Franciosa JA; COHERE Participant Physicians.

    Am J Cardiol. 2006 Dec 1;98(11):1480-4. Epub 2006 Oct 12.PMID: 17126654 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.

    Bell DS, Lukas MA, Holdbrook FK, Fowler MB.

    Curr Med Res Opin. 2006 Feb;22(2):287-96.PMID: 16466600 [PubMed - indexed for MEDLINE]Related articles

    14.

    Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.

    Krum H, Mohacsi P, Katus HA, Tendera M, Rouleau JL, Fowler MB, Coats AJ, Roecker EB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

    Am Heart J. 2006 Jan;151(1):55-61.PMID: 16368292 [PubMed - indexed for MEDLINE]Related articles

    15.

    B-type natriuretic peptide is effective therapy before care.

    Witteles R, Matsuda K, Fowler MB.

    Ann Intern Med. 2004 Dec 7;141(11):895. No abstract available. PMID: 15583244 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.

    Tang WH, Vagelos RH, Yee YG, Fowler MB.

    Am Heart J. 2004 Nov;148(5):889-94.PMID: 15523323 [PubMed - indexed for MEDLINE]Related articles

    17.

    Care management for low-risk patients with heart failure: a randomized, controlled trial.

    DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, West JA, Fowler MB, Greenwald G.

    Ann Intern Med. 2004 Oct 19;141(8):606-13.PMID: 15492340 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

    Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA.

    Circulation. 2004 Sep 28;110(13):1780-6. Epub 2004 Sep 20.PMID: 15381643 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The potential impact of soil ingestion on human mineral nutrition.

    Hooda PS, Henry CJ, Seyoum TA, Armstrong LD, Fowler MB.

    Sci Total Environ. 2004 Oct 15;333(1-3):75-87.PMID: 15364520 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link.

    Witteles RM, Tang WH, Jamali AH, Chu JW, Reaven GM, Fowler MB.

    J Am Coll Cardiol. 2004 Jul 7;44(1):78-81.PMID: 15234411 [PubMed - indexed for MEDLINE]Related articles

    21.

    Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure.

    Fowler MB.

    Am J Cardiol. 2004 May 6;93(9A):35B-9B.PMID: 15144935 [PubMed - indexed for MEDLINE]Related articles

    22.

    Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

    Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, Fowler MB, Coats AJ, Castaigne A, Scherhag A, Holcslaw TL, Packer M; Carvedilol Prospective Randomized Cumulative Survival Study Group.

    J Am Coll Cardiol. 2004 Apr 21;43(8):1423-9.PMID: 15093878 [PubMed - indexed for MEDLINE]Related articles

    23.

    NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.

    Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA.

    Eur J Heart Fail. 2004 Mar 15;6(3):343-50.PMID: 14987586 [PubMed - indexed for MEDLINE]Related articles

    24.

    Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study.

    Krum H, Roecker EB, Mohacsi P, Rouleau JL, Tendera M, Coats AJ, Katus HA, Fowler MB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

    JAMA. 2003 Feb 12;289(6):712-8.PMID: 12585949 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

    Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Staiger C, Holcslaw TL, Amann-Zalan I, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

    Circulation. 2002 Oct 22;106(17):2194-9.PMID: 12390947 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatment.

    Leier CV, Silver MA, Rich MW, Eichhorn EJ, Fowler MB, Giles TD, Johnstone DE, Le Jemtel TH, Lachmann JS, Levine TB, Armstrong PW, Dec WG, Jessup M, Howlett J, Hershberger RE, Cohn JN, Adams KF Jr, Colucci WS, Warner-Stevenson L, Hosenpud JD, Bristow MR, Pina I, Baughman KL, Binkley PF, Ventura HO, Francis GS, White M, Miller LW, Berry B, Missov E.

    Congest Heart Fail. 2002 Mar-Apr;8(2):98-124. No abstract available. PMID: 11927786 [PubMed - indexed for MEDLINE]Related articles

    27.

    Nuggets, pearls, and vignettes of master heart failure clinicians. Part 1--the medical history.

    Leier CV, Silver MA, Massie BM, Young JB, Fowler MB, Ventura HO, Hershberger RE.

    Congest Heart Fail. 2001 Sep-Oct;7(5):245-249. No abstract available. PMID: 11832662 [PubMed - as supplied by publisher]Related articles

    28.

    Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

    Leier CV, Young JB, Levine TB, Pina I, Armstrong PW, Fowler MB, Warner-Stevenson L, Cohn JN, O'Connell JB, Bristow MR, Nicklas JM, Johnstone DE, Howlett J, Ventura HO, Giles TD, Greenberg BH, Chatterjee K, Bourge RC, Yancy CW, Gottleib SS.

    Congest Heart Fail. 2001 Nov-Dec;7(6):297-308. No abstract available. PMID: 11828174 [PubMed - as supplied by publisher]Related articles

    29.

    Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure.

    Tang WH, Vagelos RH, Yee YG, Benedict CR, Willson K, Liss CL, Fowler MB.

    J Am Coll Cardiol. 2002 Jan 2;39(1):70-8. Erratum in: J Am Coll Cardiol 2002 Feb 20;39(4):746. PMID: 11755289 [PubMed - indexed for MEDLINE]Related articles

    30.

    Effect of carvedilol on survival in severe chronic heart failure.

    Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL; Carvedilol Prospective Randomized Cumulative Survival Study Group.

    N Engl J Med. 2001 May 31;344(22):1651-8.PMID: 11386263 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.

    Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M.

    J Am Coll Cardiol. 2001 May;37(6):1692-9.PMID: 11345386 [PubMed - indexed for MEDLINE]Related articles

    32.

    Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

    Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M; U.S. Carvedilol Heart Failure Study Group.

    N Engl J Med. 2001 May 3;344(18):1358-65.PMID: 11333992 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    The role of angiotensin receptor blockers in the management of chronic heart failure.

    Jamali AH, Tang WH, Khot UN, Fowler MB.

    Arch Intern Med. 2001 Mar 12;161(5):667-72. Review.PMID: 11231698 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited.

    Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB.

    Am Heart J. 2000 Jan;139(1 Pt 1):78-84.PMID: 10618566 [PubMed - indexed for MEDLINE]Related articles

    35.

    The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure.

    Fowler MB.

    J Cardiovasc Risk. 1999 Jun;6(3):141-4. Review. No abstract available. PMID: 10463139 [PubMed - indexed for MEDLINE]Related articles

    36.

    Cost effectiveness of carvedilol for heart failure.

    Delea TE, Vera-Llonch M, Richner RE, Fowler MB, Oster G.

    Am J Cardiol. 1999 Mar 15;83(6):890-6.PMID: 10190405 [PubMed - indexed for MEDLINE]Related articles

    37.

    Spontaneous postpartum coronary dissection.

    Lee FH, Yeung AC, Fowler MB, Fitzgerald PJ.

    Circulation. 1999 Feb 9;99(5):721. No abstract available. PMID: 9950672 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?

    Fowler MB.

    Eur Heart J. 1998 Dec;19 Suppl P:P17-25. Review.PMID: 9886708 [PubMed - indexed for MEDLINE]Related articles

    39.

    Joplin's neuroma or compression neuropathy of the plantar proper digital nerve to the hallux: clinicopathologic study of three cases.

    Still GP, Fowler MB.

    J Foot Ankle Surg. 1998 Nov-Dec;37(6):524-30.PMID: 9879048 [PubMed - indexed for MEDLINE]Related articles

    40.

    Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure.

    Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB.

    Ann Intern Med. 1998 Aug 15;129(4):286-93.PMID: 9729181 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Use of assumed versus measured oxygen consumption for the determination of cardiac output using the Fick principle.

    Wolf A, Pollman MJ, Trindade PT, Fowler MB, Alderman EL.

    Cathet Cardiovasc Diagn. 1998 Apr;43(4):372-80.PMID: 9554760 [PubMed - indexed for MEDLINE]Related articles

    42.

    Effects of beta blockers on symptoms and functional capacity in heart failure.

    Fowler MB.

    Am J Cardiol. 1997 Dec 4;80(11A):55L-58L.PMID: 9412543 [PubMed - indexed for MEDLINE]Related articles

    43.

    Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.

    Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA.

    J Card Fail. 1997 Sep;3(3):173-9.PMID: 9330125 [PubMed - indexed for MEDLINE]Related articles

    44.

    Assessment of left ventricular wall motion abnormalities with the use of color kinesis: a valuable visual and training aid.

    Lau YS, Puryear JV, Gan SC, Fowler MB, Vagelos RH, Popp RL, Schnittger I.

    J Am Soc Echocardiogr. 1997 Jul-Aug;10(6):665-72.PMID: 9282356 [PubMed - indexed for MEDLINE]Related articles

    45.

    AT1 and AT2 angiotensin receptor gene expression in human heart failure.

    Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB.

    Circulation. 1997 Mar 4;95(5):1201-6.PMID: 9054850 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization.

    West JA, Miller NH, Parker KM, Senneca D, Ghandour G, Clark M, Greenwald G, Heller RS, Fowler MB, DeBusk RF.

    Am J Cardiol. 1997 Jan 1;79(1):58-63.PMID: 9024737 [PubMed - indexed for MEDLINE]Related articles

    47.

    Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

    Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N.

    Circulation. 1996 Dec 1;94(11):2807-16.PMID: 8941106 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group.

    Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberger R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST, Holcslaw TL, Lukas MA.

    Circulation. 1996 Dec 1;94(11):2800-6.PMID: 8941105 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

    Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH.

    N Engl J Med. 1996 May 23;334(21):1349-55.PMID: 8614419 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Analysis of deaths in patients awaiting heart transplantation: impact on patient selection criteria.

    Haywood GA, Rickenbacher PR, Trindade PT, Gullestad L, Jiang JP, Schroeder JS, Vagelos R, Oyer P, Fowler MB.

    Heart. 1996 May;75(5):455-62.PMID: 8665337 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...